RXD:NYE-ProShares UltraShort Health Care (USD)

ETF | Trading--Inverse Equity |

Last Closing

USD 9.48

Change

-0.11 (-1.15)%

Market Cap

N/A

Volume

4.75K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Price(Change) Market Cap
SH ProShares Short S&P500

-0.04 (-0.37%)

USD 1.12B
SOXS Direxion Daily Semiconductor B..

+0.55 (+2.79%)

USD 0.85B
PSQ ProShares Short QQQ

-0.10 (-0.25%)

USD 0.58B
SPXU ProShares UltraPro Short S&P50..

-0.31 (-1.26%)

USD 0.54B
SDOW ProShares UltraPro Short Dow30

N/A

USD 0.31B
DOG ProShares Short Dow30

-0.02 (-0.07%)

USD 0.16B
SPDN Direxion Daily S&P 500® Bear ..

-0.04 (-0.36%)

USD 0.16B
RWM ProShares Short Russell2000

-0.06 (-0.32%)

USD 0.15B
DUST Direxion Daily Gold Miners Ind..

+0.19 (+3.69%)

USD 0.12B
FNGD MicroSectors FANG+ Index -3X I..

-0.25 (-1.13%)

USD 0.11B

ETFs Containing RXD

RLD:CA 0.00 % 0.61 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.54% 65% D 9% A-
Dividend Return 3.50% 59% D- 62% D
Total Return -17.03% 66% D+ 10% F
Trailing 12 Months  
Capital Gain -29.17% 68% D+ 6% D-
Dividend Return 4.03% 65% D 54% F
Total Return -25.14% 68% D+ 7% C-
Trailing 5 Years  
Capital Gain -79.99% 56% F 4% F
Dividend Return 2.07% 52% F 6% D-
Total Return -77.92% 56% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain 1.97% N/A N/A 45% F
Dividend Return 3.02% N/A N/A 39% F
Total Return 1.04% N/A N/A 24% F
Risk Return Profile  
Volatility (Standard Deviation) 249.65% N/A N/A 3% F
Risk Adjusted Return 1.21% N/A N/A 25% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike